Vienna Institute For Research In Ocular Surgery
Clinical trials sponsored by Vienna Institute For Research In Ocular Surgery, explained in plain language.
-
Higher dose eye shot aims to stretch time between treatments for vision loss
Disease control OngoingThis study is testing if switching patients with wet age-related macular degeneration (AMD) from a standard 2mg eye injection to a new, higher 8mg dose can safely allow for longer periods between treatments. It will involve 50 patients who are already receiving the standard injec…
Sponsor: Vienna Institute for Research in Ocular Surgery • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Diabetes drug tested as potential shield against Post-Cataract cloudiness
Knowledge-focused OngoingThis study aims to understand if the common diabetes medication metformin reaches the eye's lens and can slow the growth of cells that cause cloudy vision after cataract surgery. Researchers will collect lens tissue and blood samples from 40 patients with type 2 diabetes and cata…
Phase: NA • Sponsor: Vienna Institute for Research in Ocular Surgery • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:56 UTC